November 7, 2018 marks the 20th anniversary of the passing of Morgan Adams, in whose honor our organization is named. 
Funding for pediatric cancer research remains a critical issue. We cannot support the work to save the lives of our kiddos without YOU. On this day and EVERY DAY, we are incredibly grateful for the difference YOU and YOUR SUPPORT has made for kids with cancer.
In the 20 years since Morgan passed, there has been a great deal of progress made in treating kids’ cancer:
- In 1998, medulloblastoma was roughly 25% curable; today it is 80% on average.
- In 1998, ependymoma could not be treated at first relapse; today, ependymoma patients can survive relapse with an approach pioneered by Drs. Liu and Foreman.
- In 2007, the first patient with a recurrent brain stem glioma with a V600E mutation was successfully treated with a targeted therapy. Today, that treatment is now used worldwide.
- 2015 was the first time children with low grade gliomas could be successfully treated with an oral therapy at home instead of weekly hospital visits for treatment.
The majority of the advances made in treating pediatric cancer are funded by the private sector, through organizations like ours and others around the world.
Unfortunately, despite the advances, there are also many areas of pediatric cancer for which zero or very little progress has been made:
- In 1998, glioblastoma multiforme patients like Morgan had a 10% chance of survival. Today, that number has not changed.
- In 1998, diffuse intrinsic pontine gliomas were 100% fatal. Today, that number has not changed.
Kids are dying and suffering, and there is still work left for all of us to do. Research has the power to save lives, but it requires funding.
As we enter the annual season of giving, please remember us as part of your philanthropic planning. YOUR GENEROSITY MATTERS, and we will never be able to thank you enough.
In honor of Morgan, and on behalf of every other child, teen, and young adult who is enduring or has endured cancer, THANK YOU!
